CVE:SBM Sirona Biochem (SBM) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free SBM Stock Alerts C$0.06 -0.01 (-7.69%) (As of 04/19/2024 05:22 PM ET) Add Compare Share Share Today's RangeC$0.06▼C$0.0650-Day RangeC$0.06▼C$0.1152-Week RangeC$0.06▼C$0.22Volume3,000 shsAverage Volume73,503 shsMarket CapitalizationC$15.24 millionP/E RatioN/ADividend Yield1.50%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Sirona Biochem alerts: Email Address Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story About Sirona Biochem Stock (CVE:SBM)Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.Read More SBM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBM Stock News HeadlinesApril 9, 2024 | finanznachrichten.deSirona Biochem Corp.: SIRONA BIOCHEM Corporate Update April 2024April 8, 2024 | markets.businessinsider.comSIRONA BIOCHEM Corporate Update April 2024April 20, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereApril 5, 2024 | markets.businessinsider.comSirona Biochem Announces Close of Private PlacementMarch 30, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces 2023 Annual Meeting ResultsMarch 13, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum FormulationsMarch 13, 2024 | finance.yahoo.comSirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum FormulationsFebruary 21, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim in Early 2025April 20, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereFebruary 16, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Provides Update on LoanFebruary 15, 2024 | stockhouse.comSirona Biochem Provides Update on LoanFebruary 15, 2024 | markets.businessinsider.comSirona Biochem Engages Global Beauty ConsultingJanuary 29, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Announces LoanJanuary 29, 2024 | markets.businessinsider.comSirona Biochem Announces LoanJanuary 26, 2024 | financialpost.comSirona Biochem Initiates Private PlacementJanuary 24, 2024 | stockhouse.comCORRECTION -- Sirona Biochem Corporate Update January 2024January 24, 2024 | finanznachrichten.deSirona Biochem Corp.: Sirona Biochem Corporate Update January 2024January 24, 2024 | finance.yahoo.comSirona Biochem Corporate Update January 2024January 15, 2024 | financialpost.comSirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories™December 11, 2023 | finance.yahoo.comSirona Biochem Initiates GlycoProteMim™ Trademark for Anti-Aging Molecule TFC-1326December 7, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp down on Thursday (SBM)November 2, 2023 | tmcnet.comSirona Announces Support for SpaceX's Starlink Network, Allowing Radiologists to Practice from AnywhereOctober 20, 2023 | benzinga.comSirona Biochem Announces Payment of Convertible Debenture Interests in SharesOctober 18, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp flat on Monday (SBM)September 30, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp down on Friday (SBM)September 28, 2023 | tmcnet.comSirona Selects Koios, Rad.ai, & RevealDX as Founding AI Partners Ahead of November Launch EventAugust 22, 2023 | theglobeandmail.comClosing Bell: Sirona Biochem Corp up on Monday (SBM)See More Headlines Receive SBM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/20/2024Next Earnings (Estimated)6/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:SBM CUSIPN/A CIKN/A Webwww.sironabiochem.com Phone604-641-4466FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,540,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-9,810.47% Return on Assets-124.46% Debt Debt-to-Equity Ratio219.21 Current Ratio0.55 Quick Ratio2.41 Sales & Book Value Annual SalesC$683,768.00 Price / Sales22.29 Cash FlowC$0.00 per share Price / Cash Flow35.00 Book ValueC($0.01) per share Price / Book-6.00Miscellaneous Outstanding Shares254,060,000Free FloatN/AMarket CapC$15.24 million OptionableNot Optionable Beta-0.31 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Howard J. Verrico M.D. (Age 63)Ph.D., Founder, Chairman of the Board, CEO & Secretary Comp: $180.64kMr. Christopher D. Hopton C.G.A. (Age 58)CPA, CFO & Director Comp: $147.84kDr. Géraldine Deliencourt-Godefroy Ph.D.Chief Scientific Officer & DirectorKey CompetitorsResverlogixTSE:RVXAntibe TherapeuticsTSE:ATENeptune Wellness SolutionsTSE:NEPTReunion NeuroscienceTSE:REUNAeterna ZentarisTSE:AEZSView All Competitors SBM Stock Analysis - Frequently Asked Questions How have SBM shares performed in 2024? Sirona Biochem's stock was trading at C$0.12 at the beginning of 2024. Since then, SBM shares have decreased by 50.0% and is now trading at C$0.06. View the best growth stocks for 2024 here. When is Sirona Biochem's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, June 27th 2024. View our SBM earnings forecast. What other stocks do shareholders of Sirona Biochem own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). How do I buy shares of Sirona Biochem? Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:SBM) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sirona Biochem Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.